Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals.
about
Positron emission tomography imaging of prostate cancerInsights into bombesin receptors and ligands: Highlighting recent advancesIntracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor.Positron emission tomography (PET) in primary prostate cancer staging and risk assessmentBombesin receptor-mediated imaging and cytotoxicity: review and current statusF-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.A new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging.Development of hypoxia enhanced 111In-labeled Bombesin conjugates: design, synthesis, and in vitro evaluation in PC-3 human prostate cancer.Molecular imaging of prostate cancer: PET radiotracers.Peptide-based imaging agents for cancer detection.New agonist- and antagonist-based treatment approaches for advanced prostate cancer.A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer.PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy.Strain-promoted copper-free "click" chemistry for 18F radiolabeling of bombesin.In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57.Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y₁)- and GRP-Receptors-An Improvement for Breast Cancer Imaging?
P2860
Q24596241-A2D03B1A-CC3B-4603-BFF2-B0DA99A41BC9Q28081153-F93AE701-4056-49FD-A944-204E1CE78470Q30434397-5706AD17-680B-465C-A066-5F5779EA5247Q33890153-66740D20-96F7-450D-AAE6-241A840E90ABQ34684387-3A7BB819-9C4F-4FCB-9C25-B43B7A7FC662Q34912606-7CEBB7C7-BABA-4F20-9391-A5D70DB82C0AQ35009658-5E8A6FB2-9957-410D-9C8D-BB56B3BA5934Q35846757-E675935E-C318-4F9E-B7D3-75ADA3A9D5ACQ36129937-198F8B97-615F-4A12-B791-892A7F9D030DQ37585965-760A0212-7D62-4F12-8727-3641B43CF36CQ38042768-36AD336E-33D6-4E73-BE74-28F2832A7E6CQ39066397-D5EAF93B-4B11-4A3C-8FB6-E2A5FCF097BFQ39357182-191EDCF2-2A90-4A5B-91BD-FE04ED52D214Q39466193-8FB6BE57-EE68-4E0A-BE4A-E4491C5133FAQ48105870-0DD86BAF-F1AC-4E16-B8FB-82E523473D72Q57757457-BD2234E6-0BAF-4E23-A4E9-EE824B36568B
P2860
Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nuclear imaging of prostate ca ...... targeted radiopharmaceuticals.
@en
Nuclear imaging of prostate ca ...... targeted radiopharmaceuticals.
@nl
type
label
Nuclear imaging of prostate ca ...... targeted radiopharmaceuticals.
@en
Nuclear imaging of prostate ca ...... targeted radiopharmaceuticals.
@nl
prefLabel
Nuclear imaging of prostate ca ...... targeted radiopharmaceuticals.
@en
Nuclear imaging of prostate ca ...... targeted radiopharmaceuticals.
@nl
P2093
P1476
Nuclear imaging of prostate ca ...... targeted radiopharmaceuticals.
@en
P2093
Ananias HJ
Dierckx RA
Elsinga PH
Helfrich W
de Jong IJ
van de Wiele C
P304
P356
10.2174/138161208786404335
P577
2008-01-01T00:00:00Z